Epidemiology  ||| S:0 E:13 ||| NNP
and  ||| S:13 E:17 ||| CC
the  ||| S:17 E:21 ||| DT
global  ||| S:21 E:28 ||| JJ
burden  ||| S:28 E:35 ||| NN
of  ||| S:35 E:38 ||| IN
stroke  ||| S:38 E:45 ||| JJ
Stroke  ||| S:45 E:52 ||| NNP
remains  ||| S:52 E:60 ||| VBZ
one  ||| S:60 E:64 ||| CD
of  ||| S:64 E:67 ||| IN
the  ||| S:67 E:71 ||| DT
most  ||| S:71 E:76 ||| RBS
devastating  ||| S:76 E:88 ||| JJ
of  ||| S:88 E:91 ||| IN
all  ||| S:91 E:95 ||| DT
neurological  ||| S:95 E:108 ||| JJ
diseases ||| S:108 E:116 ||| NNS
,  ||| S:116 E:118 ||| ,
often  ||| S:118 E:124 ||| RB
causing  ||| S:124 E:132 ||| VBG
death  ||| S:132 E:138 ||| NN
or  ||| S:138 E:141 ||| CC
gross  ||| S:141 E:147 ||| JJ
physical  ||| S:147 E:156 ||| JJ
impairment  ||| S:156 E:167 ||| NN
or  ||| S:167 E:170 ||| CC
disability ||| S:170 E:180 ||| NN
.  ||| S:180 E:182 ||| .
As  ||| S:182 E:185 ||| IN
numerous  ||| S:185 E:194 ||| JJ
countries  ||| S:194 E:204 ||| NNS
throughout  ||| S:204 E:215 ||| IN
the  ||| S:215 E:219 ||| DT
world  ||| S:219 E:225 ||| NN
undergo  ||| S:225 E:233 ||| VBD
the  ||| S:233 E:237 ||| DT
epidemiological  ||| S:237 E:253 ||| JJ
transition  ||| S:253 E:264 ||| NN
of  ||| S:264 E:267 ||| IN
diseases ||| S:267 E:275 ||| NNS
,  ||| S:275 E:277 ||| ,
trends  ||| S:277 E:284 ||| NNS
in  ||| S:284 E:287 ||| IN
the  ||| S:287 E:291 ||| DT
prevalence  ||| S:291 E:302 ||| NN
of  ||| S:302 E:305 ||| IN
stroke  ||| S:305 E:312 ||| NNS
have  ||| S:312 E:317 ||| VBP
dramatically  ||| S:317 E:330 ||| RB
changed ||| S:330 E:337 ||| VBN
.  ||| S:337 E:339 ||| .
All  ||| S:339 E:343 ||| DT
major  ||| S:343 E:349 ||| JJ
international  ||| S:349 E:363 ||| JJ
epidemiological  ||| S:363 E:379 ||| JJ
articles  ||| S:379 E:388 ||| NNS
published  ||| S:388 E:398 ||| VBN
during  ||| S:398 E:405 ||| IN
the  ||| S:405 E:409 ||| DT
past  ||| S:409 E:414 ||| JJ
20  ||| S:414 E:417 ||| CD
years  ||| S:417 E:423 ||| NNS
addressing  ||| S:423 E:434 ||| VBG
the  ||| S:434 E:438 ||| DT
global  ||| S:438 E:445 ||| JJ
burden  ||| S:445 E:452 ||| NN
of  ||| S:452 E:455 ||| IN
stroke  ||| S:455 E:462 ||| NN
were  ||| S:462 E:467 ||| VBD
reviewed ||| S:467 E:475 ||| VBN
.  ||| S:475 E:477 ||| .
A  ||| S:477 E:479 ||| DT
focus  ||| S:479 E:485 ||| NN
was  ||| S:485 E:489 ||| VBD
placed  ||| S:489 E:496 ||| VBN
upon  ||| S:496 E:501 ||| IN
better  ||| S:501 E:508 ||| JJR
defining  ||| S:508 E:517 ||| JJ
current  ||| S:517 E:525 ||| JJ
and  ||| S:525 E:529 ||| CC
future  ||| S:529 E:536 ||| JJ
trends  ||| S:536 E:543 ||| NNS
in  ||| S:543 E:546 ||| IN
surveillance ||| S:546 E:558 ||| NN
,  ||| S:558 E:560 ||| ,
incidence ||| S:560 E:569 ||| NN
,  ||| S:569 E:571 ||| ,
burden  ||| S:571 E:578 ||| NN
of  ||| S:578 E:581 ||| IN
disease ||| S:581 E:588 ||| NN
,  ||| S:588 E:590 ||| ,
mortality ||| S:590 E:599 ||| NN
,  ||| S:599 E:601 ||| ,
and  ||| S:601 E:605 ||| CC
costs  ||| S:605 E:611 ||| NNS
associated  ||| S:611 E:622 ||| VBN
with  ||| S:622 E:627 ||| IN
stroke  ||| S:627 E:634 ||| NN
internationally ||| S:634 E:649 ||| RB
.  ||| S:649 E:651 ||| .
Despite  ||| S:651 E:659 ||| IN
the  ||| S:659 E:663 ||| DT
fact  ||| S:663 E:668 ||| NN
that  ||| S:668 E:673 ||| IN
various  ||| S:673 E:681 ||| JJ
surveillance  ||| S:681 E:694 ||| NN
systems  ||| S:694 E:702 ||| NNS
are  ||| S:702 E:706 ||| VBP
used  ||| S:706 E:711 ||| VBN
to  ||| S:711 E:714 ||| TO
identify  ||| S:714 E:723 ||| VB
stroke  ||| S:723 E:730 ||| NN
and  ||| S:730 E:734 ||| CC
its  ||| S:734 E:738 ||| PRP$
sequela  ||| S:738 E:746 ||| NN
around  ||| S:746 E:753 ||| IN
the  ||| S:753 E:757 ||| DT
world ||| S:757 E:762 ||| NN
,  ||| S:762 E:764 ||| ,
it  ||| S:764 E:767 ||| PRP
is  ||| S:767 E:770 ||| VBZ
clear  ||| S:770 E:776 ||| JJ
that  ||| S:776 E:781 ||| IN
stroke  ||| S:781 E:788 ||| NN
remains  ||| S:788 E:796 ||| VBZ
one  ||| S:796 E:800 ||| CD
of  ||| S:800 E:803 ||| IN
the  ||| S:803 E:807 ||| DT
top  ||| S:807 E:811 ||| JJ
causes  ||| S:811 E:818 ||| NNS
of  ||| S:818 E:821 ||| IN
mortality  ||| S:821 E:831 ||| NN
and  ||| S:831 E:835 ||| CC
disability-adjusted  ||| S:835 E:855 ||| JJ
life-years  ||| S:855 E:866 ||| NN
( ||| S:866 E:867 ||| -LRB-
DALYs ||| S:867 E:872 ||| NNP
)  ||| S:872 E:874 ||| -RRB-
lost  ||| S:874 E:879 ||| VBD
globally ||| S:879 E:887 ||| RB
.  ||| S:887 E:889 ||| .
Concerning  ||| S:889 E:900 ||| VBG
trends  ||| S:900 E:907 ||| NNS
include  ||| S:907 E:915 ||| VBP
the  ||| S:915 E:919 ||| DT
increase  ||| S:919 E:928 ||| NN
of  ||| S:928 E:931 ||| IN
stroke  ||| S:931 E:938 ||| JJ
mortality  ||| S:938 E:948 ||| NN
and  ||| S:948 E:952 ||| CC
lost  ||| S:952 E:957 ||| VBD
DALYs  ||| S:957 E:963 ||| JJ
in  ||| S:963 E:966 ||| IN
low-  ||| S:966 E:971 ||| JJ
and  ||| S:971 E:975 ||| CC
middle-income  ||| S:975 E:989 ||| JJ
countries ||| S:989 E:998 ||| NNS
.  ||| S:998 E:1000 ||| .
The  ||| S:1000 E:1004 ||| DT
global  ||| S:1004 E:1011 ||| JJ
economic  ||| S:1011 E:1020 ||| JJ
impact  ||| S:1020 E:1027 ||| NN
of  ||| S:1027 E:1030 ||| IN
stroke  ||| S:1030 E:1037 ||| NN
may  ||| S:1037 E:1041 ||| MD
be  ||| S:1041 E:1044 ||| VB
dire  ||| S:1044 E:1049 ||| JJ
if  ||| S:1049 E:1052 ||| IN
effective  ||| S:1052 E:1062 ||| JJ
preventive  ||| S:1062 E:1073 ||| JJ
measures  ||| S:1073 E:1082 ||| NNS
are  ||| S:1082 E:1086 ||| VBP
not  ||| S:1086 E:1090 ||| RB
implemented  ||| S:1090 E:1102 ||| VBN
to  ||| S:1102 E:1105 ||| TO
help  ||| S:1105 E:1110 ||| VB
decrease  ||| S:1110 E:1119 ||| VB
the  ||| S:1119 E:1123 ||| DT
burden  ||| S:1123 E:1130 ||| NN
of  ||| S:1130 E:1133 ||| IN
this  ||| S:1133 E:1138 ||| DT
disease ||| S:1138 E:1145 ||| NN
.  ||| S:1145 E:1147 ||| .
The  ||| S:1147 E:1151 ||| DT
global  ||| S:1151 E:1158 ||| JJ
burden  ||| S:1158 E:1165 ||| NN
of  ||| S:1165 E:1168 ||| IN
stroke  ||| S:1168 E:1175 ||| NN
is  ||| S:1175 E:1178 ||| VBZ
high ||| S:1178 E:1182 ||| JJ
,  ||| S:1182 E:1184 ||| ,
inclusive  ||| S:1184 E:1194 ||| VBG
of  ||| S:1194 E:1197 ||| IN
increasing  ||| S:1197 E:1208 ||| VBG
incidence ||| S:1208 E:1217 ||| NN
,  ||| S:1217 E:1219 ||| ,
mortality ||| S:1219 E:1228 ||| NN
,  ||| S:1228 E:1230 ||| ,
DALYs ||| S:1230 E:1235 ||| NNP
,  ||| S:1235 E:1237 ||| ,
and  ||| S:1237 E:1241 ||| CC
economic  ||| S:1241 E:1250 ||| JJ
impact ||| S:1250 E:1256 ||| NN
,  ||| S:1256 E:1258 ||| ,
particularly  ||| S:1258 E:1271 ||| RB
in  ||| S:1271 E:1274 ||| IN
low-  ||| S:1274 E:1279 ||| JJ
and  ||| S:1279 E:1283 ||| CC
middle-income  ||| S:1283 E:1297 ||| JJ
countries ||| S:1297 E:1306 ||| NNS
.  ||| S:1306 E:1308 ||| .
The  ||| S:1308 E:1312 ||| DT
implementation  ||| S:1312 E:1327 ||| NN
of  ||| S:1327 E:1330 ||| IN
better  ||| S:1330 E:1337 ||| JJR
surveillance  ||| S:1337 E:1350 ||| NN
systems  ||| S:1350 E:1358 ||| NNS
and  ||| S:1358 E:1362 ||| CC
prevention  ||| S:1362 E:1373 ||| NN
programs  ||| S:1373 E:1382 ||| NNS
are  ||| S:1382 E:1386 ||| VBP
needed  ||| S:1386 E:1393 ||| VBN
to  ||| S:1393 E:1396 ||| TO
help  ||| S:1396 E:1401 ||| VB
track  ||| S:1401 E:1407 ||| NN
current  ||| S:1407 E:1415 ||| JJ
trends  ||| S:1415 E:1422 ||| NNS
as  ||| S:1422 E:1425 ||| IN
well  ||| S:1425 E:1430 ||| RB
as  ||| S:1430 E:1433 ||| RB
to  ||| S:1433 E:1436 ||| TO
curb  ||| S:1436 E:1441 ||| VB
the  ||| S:1441 E:1445 ||| DT
projected  ||| S:1445 E:1455 ||| VBN
exponential  ||| S:1455 E:1467 ||| JJ
increase  ||| S:1467 E:1476 ||| NN
in  ||| S:1476 E:1479 ||| IN
stroke  ||| S:1479 E:1486 ||| JJ
worldwide ||| S:1486 E:1495 ||| NN
.  ||| S:1495 E:1497 ||| .
